An extracorporeal blood-cleansing device for sepsis therapy

Nature Medicine

Volumn 20, Issue 10, 2014, Pages 1211-1216

  Kang, Joo H ^a,b,c   Super, Michael ^a,g   Yung, Chong Wing ^a,b   Cooper, Ryan M ^a,b,d   Domansky, Karel ^a   Graveline, Amanda R ^a   Mammoto, Tadanori ^b   Berthet, Julia B ^a   Tobin, Heather ^b   Cartwright, Mark J ^a   Watters, Alexander L ^a   Rottman, Martin ^a,f,g   Waterhouse, Anna ^a   Mammoto, Akiko ^b   Gamini, Nazita ^a   Rodas, Melissa J ^a   Kole, Anxhela ^a   Jiang, Amanda ^b   Valentin, Thomas M ^a   Diaz, Alexander ^a   Takahashi, Kazue ^e   Ingber, Donald E ^a,b,c   more..

^a HARVARD UNIVERSITY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD UNIVERSITY   (United States)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^g 92380 Garches   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR; ENDOTOXIN; MANNOSE BINDING LECTIN; NANOBEAD; OPSONIN; BIOMIMETIC MATERIAL; MBL2 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOARTIFICIAL ORGAN; BIOSPLEEN; BLOOD CLOTTING; BLOOD FLOW; CELL INFILTRATION; CONTROLLED STUDY; ESCHERICHIA COLI; EXPERIMENTAL ENDOTOXEMIA; EXTRACORPOREAL BLOOD CLEANSING DEVICE; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IMMUNOCOMPETENT CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS; SHOCK; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE; ANIMAL; ARTIFICIAL ORGAN; BIOMEDICAL ENGINEERING; BLOOD; DEVICES; EQUIPMENT DESIGN; EXTRACORPOREAL CIRCULATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MAGNETISM; MICROBIOLOGY; MICROFLUIDIC ANALYSIS; MOLECULAR GENETICS; SPLEEN; WISTAR RAT;

ESCHERICHIA COLI; FUNGI; NEGIBACTERIA; POSIBACTERIA; RATTUS; STAPHYLOCOCCUS AUREUS;

ANIMALS; ARTIFICIAL ORGANS; BIOMEDICAL ENGINEERING; BIOMIMETIC MATERIALS; ENDOTOXINS; EQUIPMENT DESIGN; ESCHERICHIA COLI; EXTRACORPOREAL CIRCULATION; HUMANS; MAGNETICS; MALE; MANNOSE-BINDING LECTIN; MICROFLUIDIC ANALYTICAL TECHNIQUES; MOLECULAR SEQUENCE DATA; OPSONIN PROTEINS; RATS; RATS, WISTAR; SEPSIS; SPLEEN; STAPHYLOCOCCUS AUREUS;

EID: 84911445227     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3640     Document Type: Article

References (75)

1. Bone, R. C. The pathogenesis of sepsis. Ann. Intern. Med. 115, 457-469 (1991).
2. Cohen, J. The immunopathogenesis of sepsis. Nature 420, 885-891 (2002).
3. Hotchkiss, R. S. , Karl, I. E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348, 138-150 (2003).
4. Kumar, A. Optimizing antimicrobial therapy in sepsis and septic shock. Crit. Care Clin. 25, 733-751 (2009).
5. Anonymous. Focus on sepsis. Nat. Med. 18, 997 (2012).
6. O'Brien, T. F. Global surveillance of antibiotic resistance. N. Engl. J. Med. 326, 339-340 (1992).
7. Lineaweaver, W. et al. Topical antimicrobial toxicity. Arch. Surg. 120, 267-270 (1985).
8. Garnacho-Montero, J. et al. Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis. Crit. Care 10, R111 (2006).
9. Stoll, B. J. et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110, 285-291 (2002).
10. Neff, L. P. et al. Extracorporeal organ support following trauma: the dawn of a new era in combat casualty critical care. J. Trauma Acute Care Surg. 75, S120-S129 (2013).
11. Angus, D. C. Drotrecogin alfa (activated). a sad final fizzle to a roller-coaster party. Crit. Care 16, 107 (2012).
12. Chuang, Y.-C. , Chang, S.-C. , Wang, W.-K. High and increasing Oxa-51 DNA load predict mortality in Acinetobacter baumannii bacteremia: implication for pathogenesis and evaluation of therapy. PLoS ONE 5, e14133 (2010).
13. Gijs, M. A. M. Magnetic bead handling on-chip: new opportunities for analytical applications. Microfluid. Nanofluidics 1, 22-40 (2004).
14. Kang, J. H. , Choi, S. , Lee, W. , Park, J.-K. Isomagnetophoresis to discriminate subtle difference in magnetic susceptibility. J. Am. Chem. Soc. 130, 396-397 (2008).
15. Kang, J. H. et al. A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells. Lab Chip 12, 2175 (2012).
16. Xia, N. et al. Combined microfluidic-micromagnetic separation of living cells in continuous flow. Biomed. Microdevices 8, 299-308 (2006).
17. Yung, C. W. , Fiering, J. , Mueller, A. J. , Ingber, D. E. Micromagnetic-microfluidic blood cleansing device. Lab Chip 9, 1171 (2009).
18. Dommett, R. M. , Klein, N. , Turner, M. W. Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens 68, 193-209 (2006).
19. Sheriff, S. , Chang, C. Y. , Ezekowitz, R. A. B. Human mannose-binding protein carbohydrate recognition domain trimerizes through a triple alpha-helical coiled-coil. Nat. Struct. Biol. 1, 789-794 (1994).
20. Lo, K. M. et al. High level expression and secretion of Fc-X fusion proteins in mammalian cells. Protein Eng. 11, 495-500 (1998).
21. Neth, O. et al. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect. Immun. 68, 688-693 (2000).
22. Townsend, R. , Read, R. C. , Turner, M. W. , Klein, N. J. , Jack, D. L. Differential recognition of obligate anaerobic bacteria by human mannose-binding lectin. Clin. Exp. Immunol. 124, 223-228 (2001).
23. Takahashi, K. , Ip, W. E. , Michelow, I. C. , Ezekowitz, R. A. B. The mannose-binding lectin: a prototypic pattern recognition molecule. Curr. Opin. Immunol. 18, 16-23 (2006).
24. Orsini, J. et al. Microbiological profile of organisms causing bloodstream infection in critically ill patients. J. Clin. Med. Res. 4, 371-377 (2012).
25. Castanheira, M. , Farrell, S. E. , Krause, K. M. , Jones, R. N. , Sader, H. S. Contemporary diversity of, beta;-lactamases among Enterobacteriaceae in the nine U. S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent, beta;-lactamase groups. Antimicrob. Agents Chemother. 58, 833-838 (2014).
26. Morrow, B. J. et al. Activities of carbapenem and comparator agents against contemporary US Pseudomonas aeruginosa isolates from the CAPITAL surveillance program. Diagn. Microbiol. Infect. Dis. 75, 412-416 (2013).
27. Mebius, R. E. , Kraal, G. Structure and function of the spleen. Nat. Rev. Immunol. 5, 606-616 (2005).
28. Meijer, H. E. H. , Singh, M. K. , Anderson, P. D. On the performance of static mixers: a quantitative comparison. Prog. Polym. Sci. 37, 1333-1349 (2012).
29. Jayakumar, J. S. , Mahajani, S. M. , Mandal, J. C. , Iyer, K. N. , Vijayan, P. K. CFD analysis of single-phase flows inside helically coiled tubes. Comput. Chem. Eng. 34, 430-446 (2010).
30. Pass, L. J. , Schloerb, P. R. , Pearce, F. J. , Drucker, W. R. Cardiopulmonary response of the rat to Gram-negative bacteremia. Am. J. Physiol. 246, H344-H350 (1984).
31. Wiesel, P. et al. Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice. Circulation 102, 3015-3022 (2000).
32. Netea, M. G. Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing? Trends Immunol. 24, 254-258 (2003).
33. Janz, D. R. et al. Association between cell-free hemoglobin, acetaminophen, and mortality in patients with sepsis: an observational study. Crit. Care Med. 41, 784-790 (2013).
34. Rello, J. Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest 136, 832 (2009).
35. Levy, S. B. , Marshall, B. Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10, S122-S129 (2004).
36. Takahashi, K. et al. Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation. Immunobiology 216, 96-102 (2011).
37. Neth, O. et al. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect. Immun. 68, 688-693 (2000).
38. Townsend, R. , Read, R. C. , Turner, M. W. , Klein, N. J. , Jack, D. L. Differential recognition of obligate anaerobic bacteria by human mannose-binding lectin. Clin. Exp. Immunol. 124, 223-228 (2001).
39. Takahashi, K. , Ip, W. E. , Michelow, I. C. , Ezekowitz, R. A. B. The mannose-binding lectin: a prototypic pattern recognition molecule. Curr. Opin. Immunol. 18, 16-23 (2006).
40. Gilmore, J. M. , Scheck, R. A. , Esser-Kahn, A. P. , Joshi, N. S. , Francis, M. B. N-terminal protein modification through a biomimetic transamination reaction. Angew. Chem. Int. Ed. Engl. 45, 5307-5311 (2006).
41. Scheck, R. A. , Francis, M. B. Regioselective labeling of antibodies through N-terminal transamination. ACS Chem. Biol. 2, 247-251 (2007).
42. Witus, L. S. et al. Identification of highly reactive sequences for PLP-mediated bioconjugation using a combinatorial peptide library. J. Am. Chem. Soc. 132, 16812-16817 (2010).
43. Shim, M. , Shi Kam, N. W. , Chen, R. J. , Li, Y. , Dai, H. Functionalization of carbon nanotubes for biocompatibility and biomolecular recognition. Nano Lett. 2, 285-288 (2002).
44. Åkerman, M. E. , Chan, W. C. W. , Laakkonen, P. , Bhatia, S. N. , Ruoslahti, E. Nanocrystal targeting in vivo. Proc. Natl. Acad. Sci. USA 99, 12617-12621 (2002).
45. Korin, N. et al. Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels. Science 337, 738-742 (2012).
46. Takahashi, K. et al. Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation. Immunobiology 216, 96-102 (2011).
47. Petersen, S. V. , Thiel, S. , Jensen, L. , Steffensen, R. , Jensenius, J. C. An assay for the mannan-binding lectin pathway of complement activation. J. Immunol. Methods 257, 107-116 (2001).
48. Vorup-Jensen, T. et al. Recombinant expression of human mannan-binding lectin. Int. Immunopharmacol. 1, 677-687 (2001).
49. Michelow, I. C. et al. A novel l-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus. J. Biol. Chem. 285, 24729-24739 (2010).
50. Palaniyar, N. et al. Nucleic acid is a novel ligand for innate, immune pattern recognition collectins surfactant proteins A and D and mannose-binding lectin. J. Biol. Chem. 279, 32728-32736 (2004).
51. Lakshmi, C. , Hanshaw, R. G. , Smith, B. D. Fluorophore-linked zinc(ii)dipicolylamine coordination complexes as sensors for phosphatidylserine-containing membranes. Tetrahedron 60, 11307-11315 (2004).
52. Lee, J.-J. et al. Synthetic ligand-coated magnetic nanoparticles for microfluidic bacterial separation from blood. Nano Lett. 14, 1-5 (2014).
53. Ji, X. , Gewurz, H. , Spear, G. T. Mannose binding lectin (MBL) and HIV. Mol. Immunol. 42, 145-152 (2005).
54. Beck, A. , Reichert, J. M. Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies. MAbs 3, 415-416 (2011).
55. Xia, N. et al. Combined microfluidic-micromagnetic separation of living cells in continuous flow. Biomed. Microdevices 8, 299-308 (2006).
56. Yung, C. W. , Fiering, J. , Mueller, A. J. , Ingber, D. E. Micromagnetic-microfluidic blood cleansing device. Lab Chip 9, 1171 (2009).
57. Wiesel, P. et al. Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice. Circulation 102, 3015-3022 (2000).
58. Kang, J. H. et al. A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells. Lab Chip 12, 2175 (2012).
59. Kang, J. H. , Choi, S. , Lee, W. , Park, J.-K. Isomagnetophoresis to discriminate subtle difference in magnetic susceptibility. J. Am. Chem. Soc. 130, 396-397 (2008).
60. Ling, F. , Zhang, X. A numerical study on mixing in the Kenics static mixer. Chem. Eng. Commun. 136, 119-141 (1995).
61. Jayakumar, J. S. , Mahajani, S. M. , Mandal, J. C. , Iyer, K. N. , Vijayan, P. K. CFD analysis of single-phase flows inside helically coiled tubes. Comput. Chem. Eng. 34, 430-446 (2010).
62. Ofsthun, N. J. , Jensen, J. C. , Kray, M. Effect of high hematocrit and high blood flow rates on transmembrane pressure and ultrafiltration rate in hemodialysis. Blood Purif. 9, 169-176 (1991).
63. Krisper, P. , Stauber, R. E. Technology insight: artificial extracorporeal liver support-how does Prometheus compare with MARS? Nat. Clin. Pract. Nephrol. 3, 267-276 (2007).
64. Huh, D. et al. Reconstituting organ-level lung functions on a chip. Science 328, 1662-1668 (2010).
65. Ordodi, V. L. et al. Artificial device for extracorporeal blood oxygenation in rats. Artif. Organs 32, 66-70 (2008).
66. Lee, H. B. , Blaufox, M. D. Blood volume in the rat. J. Nucl. Med. 26, 72-76 (1985).
67. Kang, J. H. , Park, J.-K. Magnetophoretic continuous purification of single-walled carbon nanotubes from catalytic impurities in a microfluidic device. Small 3, 1784-1791 (2007).
68. Cooper, R. M. A Generic Pathogen Capture Technology for Sepsis Diagnosis (MIT Press, 2013).
69. Onderdonk, A. B. , Weinstein, W. M. , Sullivan, N. M. , Bartlett, J. G. , Gorbach, S. L. Experimental intra-abdominal abscesses in rats: quantitative bacteriology of infected animals. Infect. Immun. 10, 1256-1259 (1974).
70. Liang, J. et al. Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity. Int. J. Immunopharmacol. 20, 595-614 (1998).
71. Parker, S. J. , Watkins, P. E. Experimental models of Gram-negative sepsis. Br. J. Surg. 88, 22-30 (2001).
72. Pass, L. J. , Schloerb, P. R. , Pearce, F. J. , Drucker, W. R. Cardiopulmonary response of the rat to Gram-negative bacteremia. Am. J. Physiol. 246, H344-H350 (1984).
73. Remick, D. G. , Newcomb, D. E. , Bolgos, G. L. , Call, D. R. Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 13, 110-116 (2000).
74. Mammoto, A. et al. Control of lung vascular permeability and endotoxin-induced pulmonary oedema by changes in extracellular matrix mechanics. Nat. Commun. 4, 1759 (2013).
75. Lindqvist, R. Estimation of Staphylococcus aureus growth parameters from turbidity data: characterization of strain variation and comparison of methods. Appl. Environ. Microbiol. 72, 4862-4870 (2006).